Sign In
Buy SYBX
$1.20
+0.0500 (+4.35%)
At Close: Jul 31, 2026
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q4 2020 Results - Earnings Call Transcript
02:43pm, Thursday, 25'th Mar 2021
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q4 2020 Results - Earnings Call Transcript
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
06:30am, Thursday, 25'th Mar 2021
CAMBRIDGE, Mass., March 25, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financ
Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria
04:05pm, Wednesday, 24'th Mar 2021
CAMBRIDGE, Mass., March 24, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that SY
Synlogic Announces Fourth Quarter and Full Year 2020 Conference Call & Webcast
02:44pm, Tuesday, 16'th Mar 2021
CAMBRIDGE, Mass., March 16, 2021 /PRNewswire/ -- Synlogic, Inc. (NASDAQ: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the Com
Synlogic to Present at Upcoming Virtual Banking and Industry Conferences
07:00am, Monday, 15'th Feb 2021
CAMBRIDGE, Mass., Feb. 15, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that Aoi
Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory
06:30am, Tuesday, 02'nd Feb 2021
CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ -- A collaboration between MIT Voigt Lab and Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biol
Do Options Traders Know Something About Synlogic (SYBX) Stock We Don't?
09:47am, Thursday, 14'th Jan 2021
Investors need to pay close attention to Synlogic (SYBX) stock based on the movements in the options market lately.
Synlogic Outlines Upcoming Clinical Milestones
06:30am, Monday, 11'th Jan 2021
CAMBRIDGE, Mass., Jan. 11, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today outlined significa
5 Biopharma Stocks Making Big Moves Monday
11:33am, Monday, 14'th Dec 2020
Even as the broader market trades higher in reaction to the availability of the first coronavirus vaccine under emergency use authorization, a slew of biopharma stocks are moving on company-specific u
Why Is It Moving? Looking At Synlogic's Price Action Today
10:04am, Monday, 14'th Dec 2020
Synlogic's (NASDAQ: SYBX) stock is trading up 17.18% to a price of $2.76. The stock's current volume for the day is 15.18 million, which is approximately 1159.03% of its previous 30-day average volume
CAMBRIDGE, Mass., Dec. 14, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced SYNB1891
Synlogic Appoints Michael Heffernan to its Board of Directors
06:30am, Wednesday, 09'th Dec 2020
CAMBRIDGE, Mass., Dec. 9, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appoi
CAMBRIDGE, Mass., Dec. 7, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that it w
Synlogic to Present at Upcoming Virtual Banking Conference
06:30am, Wednesday, 18'th Nov 2020
CAMBRIDGE, Mass., Nov. 18, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that Aoi
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q3 2020 Results - Earnings Call Transcript
12:22pm, Saturday, 07'th Nov 2020
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q3 2020 Results - Earnings Call Transcript
